Literature DB >> 9486167

A noninternalized nondesensitized truncated AT1A receptor transduces an amplified ANG II signal.

S Conchon1, N Peltier, P Corvol, E Clauser.   

Abstract

The structural determinants of the rat angiotensin (ANG) II AT1A receptor involved in receptor internalization, desensitization, and activation are investigated by producing six mutants that had progressively larger deletions of the cytoplasmic tail (-13, -19, -24, -31, -46, and -56 residues, respectively). After stable transfection of the cDNAs into Chinese hamster ovary cells, all mutants, except the most truncated, exhibit normal [Sar1]ANG II affinities [dissociation constant (Kd) = 0.19-0.70 nM] compared with the wild-type (WT) receptor (Kd = 0.62 nM) and are able to activate a Gq/11 protein and a phospholipase C as measured by the ANG II-induced inositol phosphate (IP) turnover in the different clones. However, one of these mutants, delta 329 (deletion of 31 residues), exhibits a peculiar phenotype. This mutant shows a reduced ligand-induced internalization as measured by the acid-washing procedure (only 32% of receptors are internalized vs. 83% for WT). Moreover, the delta 329 mutant is less desensitized by a pretreatment with either ANG II (15% desensitization of ANG II-stimulated IP turnover vs. 60% for WT receptor) or the phorbol ester phorbol 12-myristate 13-acetate (no desensitization vs. 29% for WT receptor). These functional modifications of the delta 329 mutant are associated with the transduction of an amplified signal as demonstrated on both IP turnover and an integrated physiological effect of ANG II. Taken together, these data indicate that the sequence 329SLSTKMS335 of the rat AT1A receptor is involved in both receptor internalization and desensitization. This is the first demonstration that a desensitization- and internalization-defective AT1A receptor mutant is also hyperreactive and mediates augmented cellular responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9486167     DOI: 10.1152/ajpendo.1998.274.2.E336

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

Review 1.  Angiotensin and calcium signaling in the pituitary and hypothalamus.

Authors:  Cecilia Suárez; Isabel García Tornadú; Carolina Cristina; Jorge Vela; Arturo González Iglesias; Carlos Libertun; Graciela Díaz-Torga; Damasia Becu-Villalobos
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

Review 2.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

3.  Sex Differences in the Behavioral Desensitization of Water Intake Observed After Repeated Central Injections of Angiotensin II.

Authors:  Jessica Santollo; K Linnea Volcko; Derek Daniels
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

4.  Repeated administration of angiotensin II reduces its dipsogenic effect without affecting saline intake.

Authors:  Peter J Vento; Derek Daniels
Journal:  Exp Physiol       Date:  2010-03-12       Impact factor: 2.969

5.  Identification of protein kinase C phosphorylation sites in the angiotensin II (AT1A) receptor.

Authors:  H Qian; L Pipolo; W G Thomas
Journal:  Biochem J       Date:  1999-11-01       Impact factor: 3.857

6.  TRPV1 gene deficiency attenuates miniature EPSC potentiation induced by mannitol and angiotensin II in supraoptic magnocellular neurons.

Authors:  Toru Yokoyama; Takeshi Saito; Toyoaki Ohbuchi; Hirofumi Hashimoto; Hitoshi Suzuki; Hiroki Otsubo; Hiroaki Fujihara; Toshihisa Nagatomo; Yoichi Ueta
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

7.  Biased signaling of the angiotensin II type 1 receptor can be mediated through distinct mechanisms.

Authors:  Marie Mi Bonde; Jonas Tind Hansen; Samra Joke Sanni; Stig Haunsø; Steen Gammeltoft; Christina Lyngsø; Jakob Lerche Hansen
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

8.  Atrap deficiency increases arterial blood pressure and plasma volume.

Authors:  Mona Oppermann; Bernhard Gess; Frank Schweda; Hayo Castrop
Journal:  J Am Soc Nephrol       Date:  2010-01-21       Impact factor: 10.121

9.  Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice.

Authors:  Sandrine Billet; Sabine Bardin; Sonia Verp; Véronique Baudrie; Annie Michaud; Sophie Conchon; Martine Muffat-Joly; Brigitte Escoubet; Evelyne Souil; Ghislaine Hamard; Kenneth E Bernstein; Jean Marie Gasc; Jean-Luc Elghozi; Pierre Corvol; Eric Clauser
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.